Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.8749
-0.0401 (-4.38%)
At close: Aug 29, 2025, 4:00 PM
0.8875
+0.0126 (1.44%)
After-hours: Aug 29, 2025, 7:59 PM EDT
Predictive Oncology Market Cap
Predictive Oncology has a market cap or net worth of $9.53 million as of August 29, 2025. Its market cap has increased by 64.72% in one year.
Market Cap
9.53M
Enterprise Value
11.14M
1-Year Change
64.72%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since April 9, 2010, Predictive Oncology's market cap has increased from $1.74M to $9.53M, an increase of 446.53%. That is a compound annual growth rate of 11.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 9.53M | 74.32% |
| Dec 31, 2024 | 5.47M | -59.10% |
| Dec 29, 2023 | 13.37M | -44.64% |
| Dec 30, 2022 | 24.15M | -61.32% |
| Dec 31, 2021 | 62.42M | 382.16% |
| Dec 31, 2020 | 12.95M | 26.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |